This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
DaVita Clinical Research® (DCR
®), a provider of clinical research services focused on kidney research as well as a multitude of specialty therapeutic populations, today released a recap of its milestone year in 2012.
“DaVita Clinical Research experienced a very strong year in 2012,” said Dr. Mahesh Krishnan, vice president of DaVita Clinical Research. “From expanding our research capabilities to producing innovative studies with results to drive better clinical outcomes, we’re making strides to improve the quality of life for chronic kidney disease and end-stage renal disease patients around the world.”
Major initiatives and highlights for DCR in 2012 include:New research facility opened in Colorado – The new facility encompasses 35,000 square feet and is physically connected to St. Anthony Hospital in Lakewood, Colo. The 80-bed facility brought more than 50 specialized research jobs to the area and increased DCR’s physical capacity from 42 to 122 beds in North America, including the existing facility in Minnesota. The facility supports high-risk studies and has expanded ability to support both patient and healthy volunteer Phase I clinical studies.
DCR hired four key individuals to ignite the expansion at its latest clinical research facility. The new team members are Dr. Christopher Galloway, medical director; Chad Jaeger, vice president of Clinical Operations; Amy Denvir, director of Operations - Denver; and Michael Kreuter, director of Data Management.
Through this investment, DCR will continue to explore opportunities to both expand its patient-driven leadership position and diversify its ability to conduct critical research in healthy normal volunteers.
Innovative clinical research programshighlighted at industry meetings – Researchers from DCR and DaVita®, the dialysis division of DaVita HealthCare Partners Inc., presented results from a number of innovative clinical improvement programs and health economic studies originating from DaVita and its research partners. The findings were shared at three premier health care meetings in 2012: The National Kidney Foundation Spring Clinical Meeting, the 17
th Annual International Society for Pharmacoeconomics and Outcomes Research International Meeting, and the American Society of Nephrology’s Kidney Week.
DCR provides a collaborative bridge between DaVita services and the pharmaceutical and biotech research community; DCR also shares DaVita’s dedication to improving the health and well-being of kidney patients.